纳西克拉辛通过增强BNIP3介导的线粒细胞衰变和抑制铁亡来缓解败血症引起的心脏功能障碍
Rong Tang1, Minghe Jiang1, Xiao Tang1
1Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine Intensive Care Unit, Nanning, Guangxi, 533000, PR China.
Free radical biology & medicine
|June 28, 2025
概括
纳西克拉辛 (Narc) 通过抑制铁亡和促进线粒细胞衰变,保护免受败血症引起的心肌功能障碍. 这种植物性化合物改善了存活率和心脏功能,为与败血症有关的心脏损伤提供了潜在的治疗方法.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 败血症引起的心肌功能障碍 (SIMD) 是败血症死亡的主要原因.
- SIMD涉及炎症,氧化应激和线粒体功能受损.
- 目前对SIMD的治疗方法有限.
研究的目的:
- 调查纳西克拉辛 (Narc) 在缓解SIMD方面的潜力.
- 确定Narc是否抑制铁亡并促进SIMD中的线粒.
- 阐明Narc行动的潜在分子机制.
主要方法:
- 使用了SIMD.的脂聚糖 (LPS) 和结和穿孔 (CLP) 鼠标模型.
- 以预防性方式使用Narc,并评估存活率和心脏功能 (LVEF,FS,心脏输出).
- 进行了生物化学分析,细胞活力测试,线粒体呼吸分析和分子研究 (siRNA,AAV9).
主要成果:
- 在小鼠模型中,narc显著改善了生存率和恢复心脏功能.
- 麻醉治疗减少了铁过载,脂质过氧化,并补充了谷氨,这是铁灭抑制的标志.
- 麻醉剂增强了线粒体呼吸,稳定了膜潜力,并通过BNIP3.3促进了线粒体.
- 确定了BNIP3作为一个中心目标,其敲击取消了Narc的保护作用.
结论:
- 纳西克拉辛有效地减轻了败血症引起的心肌功能障碍.
- 麻醉剂通过双重机制起作用:抑制铁和促进BNIP3依赖的线粒.
- 麻醉剂在与败血症相关的心脏损伤方面显示出显著的治疗潜力.
相关概念视频
Necrosis
4.9K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.9K
Heart Failure Drugs: Inotropic Agents
743
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
743
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K


